BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//VLAB - ECPv6.17.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:VLAB
X-ORIGINAL-URL:https://vlab.org
X-WR-CALDESC:Events for VLAB
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/Los_Angeles
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20150308T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20151101T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20160313T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20161106T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20170312T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20171105T090000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20160419T180000
DTEND;TZID=America/Los_Angeles:20160419T203000
DTSTAMP:20250225T184259Z
CREATED:20190319T212142Z
LAST-MODIFIED:20250225T184259Z
UID:1131-1461088800-1461097800@vlab.org
SUMMARY:Rewriting DNA: Big Returns from Gene Editing
DESCRIPTION:Rewriting DNA\nBig Returns from Gene Editing\n			\n				\n				\n				\n				\n				Tuesday\, April 19\, 2016\n6:00 pm to 8:30 pm\n6:00 pm: Reception and networking\n7:00 pm: Panel discussion (with Q&A) \n			\n				\n				\n				\n				\n				\n				\n			\n				\n				\n				\n				\n				Imagine cutting and pasting genes in DNA\, just like editing words in a document on a computer. CRISPR-Cas9 gene editing technology does just that\, making it possible to replace genetic material with a simpler\, cheaper\, more precise method than ever before. Dubbed “the biggest biotech discovery of the century” supporters of CRISPR call out benefits such as potential cures for diseases like cancer\, malaria\, and cystic fibrosis; increased crop yields; and correcting genetic defects. Opponents raise ethical concerns citing the law of unintended consequences\, designer babies\, and interspecies organ transplants. \nWith the market for gene editing expected to reach $3.5 billion by 2019\, the stakes for companies\, scientists\, and entrepreneurs are high with battles already being waged over patents. Notably\, pharmaceutical companies are jumping in to protect their interests\, too. \n\nWill the winner take all?\nCan CRISPR eradicate viruses like AIDS and Zika?\nCan science truly control genetics?\n\n			\n			\n				\n				\n				\n				\n			\n				\n				\n				\n				\n				\n				\n				\n				\n				\n				\n				Moderator\n			\n				\n				\n				\n				\n				Ted Driscoll\, Parther & Digital Healthcare Lead\, Claremont Creek Ventures \n			\n				\n				\n				\n				\n				Panelists\n			\n				\n				\n				\n				\n				Riley Doyle\, CEO & Technical Lead\, Desktop Genetics \nEdward Lanphier\, President & CEO\, Sangamo BioSciences \nJenny Rooke\, PhD & Managing Director\, 5 Prime Ventures \n			\n			\n				\n				\n				\n				\n			\n				\n				\n				\n				\n				\n				\n				\n				\n				\n				\n				SRI International Conference Center\n333 Ravenswood Drive\nMenlo Park\, CA 94025
URL:https://vlab.org/event/gene-editing/
LOCATION:SRI International Conference Center\, 333 Ravenswood Drive\, Menlo Park\, CA\, 94025\, United States
CATEGORIES:VLAB Panel
ATTACH;FMTTYPE=image/jpeg:https://vlab.org/wp-content/uploads/2016/02/gene-editing-scaled.jpg
END:VEVENT
END:VCALENDAR